These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 3093212)
1. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients. Pisani F; Fazio A; Oteri G; Ruello C; Gitto C; Russo F; Perucca E Epilepsia; 1986; 27(5):548-52. PubMed ID: 3093212 [TBL] [Abstract][Full Text] [Related]
2. Lack of interaction of gabapentin with carbamazepine or valproate. Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239 [TBL] [Abstract][Full Text] [Related]
3. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid. Minkova GD; Getova DP Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330 [TBL] [Abstract][Full Text] [Related]
4. Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients. McKee PJ; Blacklaw J; Butler E; Gillham RA; Brodie MJ Epilepsy Res; 1992 May; 11(3):193-8. PubMed ID: 1396534 [TBL] [Abstract][Full Text] [Related]
5. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients]. Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473 [TBL] [Abstract][Full Text] [Related]
6. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate]. Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769 [TBL] [Abstract][Full Text] [Related]
7. Carbamazepine/valproic acid interaction in man and rhesus monkey. Levy RH; Moreland TA; Morselli PL; Guyot M; Brachet-Liermain A; Loiseau P Epilepsia; 1984 Jun; 25(3):338-45. PubMed ID: 6426944 [TBL] [Abstract][Full Text] [Related]
8. Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children. Cepelak I; Zanić Grubisić T; Mandusić A; Rekić B; Lenicek J Clin Chim Acta; 1998 Aug; 276(2):121-7. PubMed ID: 9764730 [TBL] [Abstract][Full Text] [Related]
9. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Vasudev K; Goswami U; Kohli K Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972 [TBL] [Abstract][Full Text] [Related]
10. Carbamazepine-valnoctamide interaction in epileptic patients: in vitro/in vivo correlation. Pisani F; Haj-Yehia A; Fazio A; Artesi C; Oteri G; Perucca E; Kroetz DL; Levy RH; Bialer M Epilepsia; 1993; 34(5):954-9. PubMed ID: 8104783 [TBL] [Abstract][Full Text] [Related]
11. Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy. Bondareva IB; Jelliffe RW; Andreeva OV; Bondareva KI J Clin Pharm Ther; 2011 Oct; 36(5):625-36. PubMed ID: 21062333 [TBL] [Abstract][Full Text] [Related]
12. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents. Steinborn B; Galas-Zgorzalewicz B Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261 [TBL] [Abstract][Full Text] [Related]
13. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy. Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276 [TBL] [Abstract][Full Text] [Related]
14. Increased valproate serum concentrations upon carbamazepine cessation. Jann MW; Fidone GS; Israel MK; Bonadero P Epilepsia; 1988; 29(5):578-81. PubMed ID: 3137021 [TBL] [Abstract][Full Text] [Related]
15. Color vision in epileptic adolescents treated with valproate and carbamazepine. Verrotti A; Lobefalo L; Priolo T; Rapinese M; Trotta D; Morgese G; Gallenga PE; Chiarelli F Seizure; 2004 Sep; 13(6):411-7. PubMed ID: 15276145 [TBL] [Abstract][Full Text] [Related]
16. The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children. Liu H; Delgado MR Epilepsy Res; 1994 Mar; 17(3):257-69. PubMed ID: 8013448 [TBL] [Abstract][Full Text] [Related]
17. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy. Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401 [TBL] [Abstract][Full Text] [Related]
18. Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide. Pisani F; Fazio A; Oteri G; Spina E; Perucca E; Bertilsson L Br J Clin Pharmacol; 1988 May; 25(5):611-3. PubMed ID: 3136790 [TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848 [TBL] [Abstract][Full Text] [Related]
20. Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy. Schoeman JF; Elyas AA; Brett EM; Lascelles PT Dev Med Child Neurol; 1984 Dec; 26(6):756-64. PubMed ID: 6440825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]